Viewing Study NCT05907304


Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2025-12-27 @ 1:12 PM
Study NCT ID: NCT05907304
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-22
First Post: 2023-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X Mutations
Sponsor: Erasca, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module